← back to search

Patricia Ho

Columbia University Irving Medical Center · US
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, CAR-T cell therapy research, and Single-cell and spatial transcriptomics.
h-index
18
citations
2,715
works
62
NIH funding
primary concept
Biology
email

Recent publications

Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
Nature Medicine 2025cited by 48position: middledoi
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Cancer Cell 2023cited by 92position: firstdoi
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens
Nature Genetics 2023cited by 58position: middledoi
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
Nature Communications 2023cited by 39position: middledoi
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
Cell 2022cited by 206position: middledoi
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Nature Cancer 2022cited by 47position: middledoi
A molecular single-cell lung atlas of lethal COVID-19
Nature 2021cited by 720position: middledoi
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
Nature Genetics 2021cited by 261position: middledoi
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Research Square 2021cited by 6position: middledoi
Mechanisms and therapeutic implications of hypermutation in gliomas
Nature 2020cited by 693position: middledoi
CloneSifter: enrichment of rare clones from heterogeneous cell populations
BMC Biology 2020cited by 26position: middledoi
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
Nature Communications 2019cited by 60position: middledoi
CloneRetriever: retrieval of rare clones from heterogeneous cell populations
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Johannes C. Melms · Royal College of Physicians3 papers (2021–2023)Benjamin Izar · Columbia University Irving Medical Center3 papers (2021–2023)Lindsay Caprio · Columbia University Irving Medical Center2 papers (2023–2023)Meri Rogava · Northwell Health2 papers (2021–2023)Casey R. Ager · Mayo Clinic in Arizona2 papers (2021–2023)Ryan O’Rourke · Brown University2 papers (2019–2020)Pratiti Bandopadhayay · Harvard University2 papers (2019–2020)David Feldman · Massachusetts Institute of Technology2 papers (2019–2020)Amit Dipak Amin · University of Cambridge2 papers (2023–2023)Silvana Konermann · Palo Alto Institute2 papers (2019–2020)Cory M. Johannessen · Novartis (China)2 papers (2019–2020)Paul C. Blainey · Broad Institute2 papers (2019–2020) · 2 papers (2019–2020) · 2 papers (2019–2020) · 2 papers (2019–2020) · 2 papers (2019–2020)Rameen Beroukhim · Broad Institute2 papers (2019–2020)Nasser K. Altorki · Cornell University1 papers (2023–2023)Matan Hofree · Broad Institute1 papers (2023–2023) · 1 papers (2021–2021)